Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment
Dual Diagnosis Psychosis and Substance Abuse: Short- and Middle-term Changes in Symptomatology After Visiting a Group Education Programme to Reduce Consumption of Cannabis
Intention of the study is to examine, if the symptomatology of dual diagnosis patients is less severe after a special indication training for reduction of cannabis consumption in comparison to unspecified trainings.
Point of interest is psychopathology and consumerism.
研究概览
地位
详细说明
Dual diagnosis patients (psychosis and cannabis abuse) account for more clinical admissions than single diagnosis patients.
Cannabis misuse is a known risk factor for recurrence of psychosis.
A specified intervention on the basis of a manual for schizophrenic substance abusers is administered to inpatients in a specialized unit for young schizophrenic patients in a psychiatric hospital.
The control group, same indication (psychotic disorder and cannabis misuse) receives social competence training (specified for schizophrenic patients as well).
Admission to groups is randomly.
研究类型
注册 (预期的)
阶段
- 阶段1
联系人和位置
学习地点
-
-
Baden-Württemberg
-
Konstanz、Baden-Württemberg、德国、78462
- University of Konstanz
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Clinical diagnosis of schizophrenia and disorders with psychotic features
- Misuse of cannabis during 12 months preceding admission to hospital
Exclusion Criteria:
- Not able to attend training twice a week for 45 minutes (concentration, attention, psychotic symptoms, agitation)
- Discharge from hospital before completion of training
学习计划
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：ACT
Anti-Cannabis-Consumption-Training
|
8 sessions within 4 weeks (twice a week, 45 minutes each) Cognitive behavioral therapy with focus on cannabis abuse
|
|
有源比较器：CG
Control group
|
8 sessions within 4 weeks (twice a week, 45 minutes) training to develop and ameliorate social competences
|
研究衡量的是什么？
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
PANSS Positive and Negative Symptom Scale
大体时间：post intervention, six months follow-up
|
post intervention, six months follow-up
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Urinstatus for cannabinoids
大体时间：weekly during and post intervention, follow-up
|
weekly during and post intervention, follow-up
|
合作者和调查者
调查人员
- 首席研究员：Hans Watzl, Dr.、University of Konstanz
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.